Ticker
VCELCompany Name
VERICEL CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Current Assets | Inventory | Current Liabilities | Quick Ratio |
---|---|---|---|---|
6/30/2025 | $ 204.58M | $ 16.83M | $ 41.13M | 4.56 |
3/31/2025 | $ 197.64M | $ 17.11M | $ 39.45M | 4.58 |
12/31/2024 | $ 212.78M | $ 17.37M | $ 50.29M | 3.89 |
9/30/2024 | $ 190.52M | $ 15.76M | $ 41.35M | 4.23 |
6/30/2024 | $ 197.39M | $ 14.89M | $ 43.86M | 4.16 |
3/31/2024 | $ 189.72M | $ 13.56M | $ 36.47M | 4.83 |
12/31/2023 | $ 205.63M | $ 13.09M | $ 45.75M | 4.21 |
9/30/2023 | $ 186.21M | $ 12.62M | $ 35.95M | 4.83 |
6/30/2023 | $ 182.87M | $ 13.88M | $ 35.61M | 4.75 |
3/31/2023 | $ 177.54M | $ 15.37M | $ 28.75M | 5.64 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(AssetsC - Inventory) / LiabilitesC
(=) Quick Ratio
Quick Ratio for VERICEL CORP is calculated as follows: (AssetsC [ $ 125.38M ] - Inventory [ $ 10.08M ]) / LiabilitesC [ $ 21.31M ]
(=) Quick Ratio [ 5.41 ]
Minimum
Dec 31, 2024
Maximum
Sep 30, 2021
Average
Median
filtered constituents | 3.12K |
---|---|
min | -0.73 |
max | 5.45 |
average | 1.55 |
median | 1.23 |
std | 1.17 |